Bevacizumab in Patients Treated with Stereotactic Radiosurgery for Recurrent Malignant Gliomas is Associated with Improved Overall Survival
Publication
, Conference
Cuneo, KC; Vredenburgh, JJ; Sampson, JH; Reardon, DA; Desjardins, A; Willett, CG; Kirkpatrick, JP
Published in: International Journal of Radiation Oncology*Biology*Physics
November 2009
Duke Scholars
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
November 2009
Volume
75
Issue
3
Start / End Page
S249 / S250
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Cuneo, K. C., Vredenburgh, J. J., Sampson, J. H., Reardon, D. A., Desjardins, A., Willett, C. G., & Kirkpatrick, J. P. (2009). Bevacizumab in Patients Treated with Stereotactic Radiosurgery for Recurrent Malignant Gliomas is Associated with Improved Overall Survival. In International Journal of Radiation Oncology*Biology*Physics (Vol. 75, pp. S249–S250). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2009.07.576
Cuneo, K. C., J. J. Vredenburgh, J. H. Sampson, D. A. Reardon, A. Desjardins, C. G. Willett, and J. P. Kirkpatrick. “Bevacizumab in Patients Treated with Stereotactic Radiosurgery for Recurrent Malignant Gliomas is Associated with Improved Overall Survival.” In International Journal of Radiation Oncology*Biology*Physics, 75:S249–50. Elsevier BV, 2009. https://doi.org/10.1016/j.ijrobp.2009.07.576.
Cuneo KC, Vredenburgh JJ, Sampson JH, Reardon DA, Desjardins A, Willett CG, et al. Bevacizumab in Patients Treated with Stereotactic Radiosurgery for Recurrent Malignant Gliomas is Associated with Improved Overall Survival. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2009. p. S249–50.
Cuneo, K. C., et al. “Bevacizumab in Patients Treated with Stereotactic Radiosurgery for Recurrent Malignant Gliomas is Associated with Improved Overall Survival.” International Journal of Radiation Oncology*Biology*Physics, vol. 75, no. 3, Elsevier BV, 2009, pp. S249–50. Crossref, doi:10.1016/j.ijrobp.2009.07.576.
Cuneo KC, Vredenburgh JJ, Sampson JH, Reardon DA, Desjardins A, Willett CG, Kirkpatrick JP. Bevacizumab in Patients Treated with Stereotactic Radiosurgery for Recurrent Malignant Gliomas is Associated with Improved Overall Survival. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2009. p. S249–S250.
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
November 2009
Volume
75
Issue
3
Start / End Page
S249 / S250
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences